Effect of Mechanical Power-based Lung-protective Ventilation During One-lung Ventilation
Incidence of Postoperative Pulmonary Complications Between Mechanical Power-based Versus Conventional Lung Protective Ventilation During One-lung Ventilation: a Randomized Controlled Trial
The goal of this clinical trial is to determine whether a mechanical power-based lung-protective ventilation strategy during one-lung ventilation reduces the incidence of postoperative pulmonary complications in adult patients undergoing lung resection surgery.
Mechanical power during pressure-regulated volume control mode is calculated using the formula below.
Mechanical power (J/min) = 0.098 x respiratory rate x tidal volume x (inspiratory airway pressure above positive end-expiratory pressure + positive end-expiratory pressure)
The main questions it aims to answer are:
- Does a mechanical power-based lung-protective ventilation strategy significantly lower the incidence of major postoperative pulmonary complications compared to conventional ventilation?
- How does this strategy impact intraoperative hemodynamic and vital profiles (e.g., blood pressure, cardiac output, vasopressor requirements, and blood oxygen saturation) during one-lung ventilation?
Participants will:
- Be randomized to receive either a mechanical power-based lung-protective ventilation strategy or a conventional lung-protective ventilation strategy exclusively during one-lung ventilation.
- Be closely monitored for the occurrence of major postoperative pulmonary complications (atelectasis, pneumonia, acute respiratory distress syndrome, and pulmonary aspiration) and adverse events for 1 month postoperatively.
研究概览
地位
条件
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Heejoon Jeong Anesthesiologist, Professor, MD
- 电话号码:+82-2-3410-0841
- 邮箱:heejoonjeong@skku.edu
学习地点
-
-
-
Seoul、韩国、06351
- Samsung Medical Center
-
首席研究员:
- Heejoon Jeong, MD
-
接触:
- Heejoon Jeong Anesthesiologist, Professor, MD
- 电话号码:+82-2-3410-0841
- 邮箱:heejoonjeong@skku.edu
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria
- American Society of Anesthesiologists (ASA) physical status I-III
- Elective thoracic surgery requiring lung lobectomy under one-lung ventilation
- Age 18 years or older
- Written informed consent obtained from the patient
Exclusion Criteria
- Prior history of thoracic surgery
- Emergency surgery
- Pregnancy or lactation
- Known contraindication to one-lung ventilation
- Inability to provide informed consent or cooperate with the study protocol
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Mechanical power-based lung protective ventilation group
Patients in this group will receive the mechanical power-based lung-protective ventilation strategy during one-lung ventilation.
|
Initial Settings 1) Tidal Volume: 4-6 mL/kg of predicted body weight 2) Positive End-Expiratory Pressure: Set to the value that minimizes driving pressure 3) Respiratory Rate: Adjusted to maintain an end-tidal carbon dioxide of 35-45 mmHg Protocol
|
|
有源比较器:Conventional ventilation group
Patients in this group will receive the conventional lung-protective ventilation strategy during one-lung ventilation.
|
Ventilator Settings
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Postoperative pulmonary complication
大体时间:From enrollment to 7 days postoperatively
|
Composite of respiratory diagnoses that share common pathophysiological mechanisms, including pulmonary collapse and airway contamination:
|
From enrollment to 7 days postoperatively
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Clavien-Dindo classification
大体时间:From enrollment to 30 days postoperatively
|
The Clavien-Dindo classification is a standardized grading system for postoperative complications based on the therapeutic treatment required to manage the complication. The Clavien-Dindo classification grades surgical complications according to the invasiveness and complexity of the therapy needed to treat them, ranging from any deviation from the normal postoperative course to death. Grading Scale Overview Grade I: Any deviation from the normal postoperative course without the need for pharmacological treatment. Grade II: Requiring pharmacological treatment with drugs other than those allowed for Grade I complications Grade III: Requiring surgical, endoscopic, or radiological intervention. Grade IV: Life-threatening complication. Grade V: Death of a patient |
From enrollment to 30 days postoperatively
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.